focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
Let the efficacy of the research do the talking...or hobbling...todays news was good, but expected. Its one step at a time...onto another level....from mice to humans (not easy).
If I am not mistaken the Hemo approach/technology has a multitude of applications, but it is a new/emerging and increasingly accepted approach with anticipated efficacious outcomes.
Best wishes to Hemo.
Given the struggles involved by therapeutic research to get to human trials ...lets wish them success. The approach is `novel'. To get to Human Trials is quiet an achievement. Lets congratulate the endeavors of Hemo (and other driven scientists)., for their commitment to theory/research, `lab' testing and, eventual,`Human Trials'.
Lets hope it is efficacious...
I am not deramping HE1. Their 75% plus discounted fundraising, after an already phenomenal fall from their initial placing is concerning. Now I look at market cap. For that justify income against expenditure.
In the Final Analysis for those investing in small cap stocks is.... a) will the endeavors of invested company be successful B) do the executives care more about investors or proof of concept C) are institutional investors using small fodder investors to transfer their savings to stock markets that, of course allows corporate investors to offload to naive investors.
Lets see the placing price
I hope all goes well...my historical experience is not to trust the ceo's. Certainly cannot trust the rampers/derampers on bulletin boards-many of which are sponsored by corporate interests, or pursue their organized self interest...its market anarchy with no rules. Our governments/regulatory authorities let it happen. Ask yourself who gains. I live in the South East of England....